Amy C. Peterson - 15 May 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Reporting relationship: EVP Prod Dev & Med Aff & CMO
Issuer ticker: EXEL
Reported as of: 15 May 2025
Net transaction value: -$2,809,854
SEC form: 4
Accepted by SEC: 16 May 2025, 20:57:07 UTC
Prior SEC filing: 31 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Nina Ayer, Attorney in Fact

Key filing fact

Amy C. Peterson filed Form 4 for EXELIXIS, INC. (EXEL) on 16 May 2025.

Key facts

This page summarizes Amy C. Peterson's Form 4 filing for EXELIXIS, INC. (EXEL).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 May 2025, 20:57.

Change

Previous filing in this sequence was filed on 31 Mar 2025.
Current net transaction value: -$2,809,854.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001682735 Primary reporting owner

Peterson Amy C.

Relationship: EVP Prod Dev & Med Aff & CMO
Address: 1851 HARBOR BAY PARKWAY, ALAMEDA
Signature: /s/ Nina Ayer, Attorney in Fact
Signature date: 16 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Tax liability

Transaction value: $370,729
Shares: -8,303
Change %: -1.6%
Price: $44.65
Shares after: 498,169
Date: 15 May 2025
Ownership: Direct
Footnotes: F1, F2

EXEL transaction

Common Stock

Options Exercise

Transaction value: $870,000
Shares: +40,000
Change %: +8%
Price: $21.75
Shares after: 538,169
Date: 16 May 2025
Ownership: Direct
Footnotes: F2

EXEL transaction

Common Stock

Sale

Transaction value: $3,309,125
Shares: -72,776
Change %: -14%
Price: $45.47
Shares after: 465,393
Date: 16 May 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXEL transaction Derivative

Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -40,000
Change %: -25%
Price: $0.000000
Shares after: 120,000
Date: 16 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $21.75
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded February 23, 2024.

Footnote F2

Includes 453,166 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.

Footnote F3

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $45.08 to $46.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

Footnote F4

The option, representing the right to purchase a total of 160,000 shares of Common Stock, 40,000 shares became exercisable on August 24, 2024 and the remainder will become fully exercisable on August 24, 2027.